Dose-response characteristics of high-viscosity hydroxypropylmethylcellulose in subjects at risk for the development of type 2 diabetes mellitus

Diabetes Technology and Therapeutics

Volumn 11, Issue 2, 2009, Pages 119-125

  Maki, Kevin C ^a,b   Reeves, Matthew S ^a,b   Carson, Michael L ^c   Miller, Marvin P ^c   Turowski, MacIej ^c   Rains, Tia M ^a,b   Anderson, Kerr ^c   Papanikolaou, Yanni ^d   Wilder, Donna M ^a,b  

^a Provident Clinical Research   (United States)

^b Provident Clinical Research and Consulting Inc   (United States)

^c DOW CHEMICAL COMPANY   (United States)

^d Nutritional Strategies   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CELLULOSE; GLUCOSE; HYDROXYPROPYLMETHYLCELLULOSE; INSULIN;

ADULT; ARTICLE; BLOOD VISCOSITY; BODY MASS; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOOD INTAKE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AREA UNDER CURVE; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; METHYLCELLULOSE; MIDDLE AGED; RISK FACTORS; VISCOSITY;

EID: 58449136846     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2008.0036     Document Type: Article

References (37)

1. Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention: Diabetes Data & Trends. http://www.cdc.gov/diabetes/statistics/prev/ national/figpersons.htm (accessed December 2007).
2. rd, Chew EY; Early Treatment Diabetic Retinopathy Study Research Group: Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: Early Treatment Diabetic Retinopathy Study Report no. 27. Diabetes Care 2005;28:617-625.
3. Salmeron J, Ascherio A, Rimm EB, Colditz GA, Spiegelman D, Jenkins DJ, Stampfer MJ, Wing AL, Willett WC: Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 1997;20:545-550.
4. Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC: Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 1997;277:472-477.
5. Wolever TM: Dietary carbohydrates and insulin action in humans. Br J Nutr 2000;83(Suppl 1):S97-S102.
6. Jenkins DJ, Kendall CW, Augustin LS, Vuksan V: High-complex carbohydrate or lente carbohydrate foods? Am J Med 2002;113(Suppl 9B):30S-37S.
7. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM: a balanced overview. Diabetes Care 1992;15:318-368.
8. Maki KC: Dietary factors in the prevention of diabetes mellitus and coronary artery disease associated with the metabolic syndrome. Am J Cardiol 2004;93(Suppl):12C-17C.
9. Chiasson J, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M; STOP NIDDM Trial Research Group: Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 2003;290:486-494.
10. Chiasson J, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M; STOP NIDDM Trial Research Group: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002;359:2072-2077.
11. Uusitupa M, Lindi V, Louheranta A, Salopuro T, Lindstrom J, Tuomilehto J; Finnish Diabetes Prevention Study Group: Long-term improvement in insulin sensitivity by changing lifestyles of people with impaired glucose tolerance: 4-year results from the Finnish Diabetes Prevention Study. Diabetes 2003;52:2532-2538.
12. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
13. Quinn CE, Hamilton PK, Lockhart CJ, McVeigh GE: Thiazolidinediones: effects on insulin resistance and the cardiovascular system. Br J Pharmacol 2008;153:636-645.
14. Maki KC, Galant R, Samuel P, Tesser J, Witchger MS, Ribaya-Mercado JD, Blumberg JB, Geohas J: Effects of consuming foods containing oat beta-glucan on blood pressure, carbohydrate metabolism and biomarkers of oxidative stress in men and women with elevated blood pressure. Eur J Clin Nutr 2007;61:786-795.
15. Pastors JG, Pastors JG, Blaisdell PW, Balm TK, Asplin CM, Pohl SL: Psyllium fiber reduces rise in postprandial glucose and insulin concentrations in patients with non-insulin-dependent diabetes. Am J Clin Nutr 1991;53:1431-1435.
16. Groop PH, Aro A, Stenman S, Groop L: Long-term effects of guar gum in subjects with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1993;58:513-518.
17. Wursch P, Pi-Sunyer FX: The role of viscous soluble fiber in the metabolic control of diabetes. A review with special emphasis on cereals rich in beta-glucan. Diabetes Care 1997;20:1774-1780.
18. Ebeling P, Yki-Jarvinen H, Aro A, Helve E, Sinisalo M, Koivisto VA: Glucose and lipid metabolism and insulin sensitivity in type 1 diabetes: the effect of guar gum. Am J Clin Nutr 1988;48:98-103.
19. Jenkins DJ, Wolever TM, Leeds AR, Gassull MA, Haisman P, Dilawari J, Goff DV, Metz GL, Alberti KG: Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity. Br Med J 1978;1:1392-1394.
20. Wood PJ, Braaten JT, Scott FW, Riedel KD, Wolynetz MS, Collins MW: Effect of dose and modification of viscous properties of oat gum on plasma glucose and insulin following an oral glucose load. Br J Nutr 1994;72:731-743.
21. Reppas C, Meyer JH, Sirois PJ, Dressman JB: Effects of hydroxypropylmethylcellulose on gastrointestinal transit and luminal viscosity in dogs. Gastroenterology 1991;100:1217-1223.
22. Reppas C, Greenwood DE, Dressman JB: Longitudinal versus radial effects of hydroxypropyl-methylcellulose on gastrointestinal glucose absorption in dogs. Eur J Pharm Sci 1999;8:211-219.
23. Reppas C, Adair CH, Barnett JL, Berardi RR, DuRoss D, Swidan SZ, Thill PF, Tobey SW, Dressman JB: High viscosity hydroxypropylmethylcellulose reduces postprandial blood glucose concentrations in NIDDM patients. Diabetes Res Clin Pract 1993;22:61-69.
24. Maki KC, Carson ML, Miller MP, Turowski M, Bell M, Wilder DM, Reeves MS: High-viscosity hydroxypropylmethylcellulose blunts postprandial glucose and insulin responses. Diabetes Care 2007;30:1039-1043.
25. Maki KC, Carson ML, Miller MP, Turowski M, Bell M, Wilder D, Rains TM, Reeves MS: High-viscosity hydroxypropylmethylcellulose lowers postprandial insulin levels. J Nutr 2008;138:292-296.
26. Kirkman MS, Shankar RR, Shankar S, Shen C, Brizendine E, Baron A, McGill J: Treating postprandial hyperglycemia does not appear to delay progression of early type 2 diabetes: the Early Diabetes Intervention Program. Diabetes Care 2006;9:2095-2101.
27. Brouns F, Bjorck I, Frayn KN, Gibbs AL, Lang V, Slama G, Wolever TMS: Glycaemic index methodology. Nutr Res Rev 2005;18:145-171.
28. Stern MP, Williams K, Haffner SM: Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 2002;136:575-581.
29. Genuth S, Alberti KG, Bennett P, Buse J, DeFronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Sheffes M, Stern M, Tuomilehto J, Zimmet P: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-3167.
30. Abdul-Ghani MA, Williams K, DeFronzo R, Stern M: Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose. Diabetes Care 2006;29:1613-1618.
31. Abdul-Ghani MA, Tripathy D, DeFronzo RA: Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2006;29:1130-1139.
32. Santos EM; Expert Panel: Final report of the safety assessment of hydroxyethylcellulose, hydroxypropylcellulose, methylcellulose, hydroxypropylmethylcellulose, and cellulose gum. J Am Coll Toxicol 1986;5:1-59.
33. Braun WH, Ramsey JC, Gehring PJ: The lack of significant absorption of methylcellulose, viscosity 3300 CP, from the gastrointestinal tract following single and multiple oral doses to the rat. Food Cosmetic Toxicol 1974;12:373-376.
34. Spiller RC: Pharmacology of dietary fibre. Pharmacol Ther 1994;62:407-427.
35. Executive summary of the Third Report of the National Cholesterol Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;258:2486-2497.
36. Maki KC, Davidson MH, Malik KC, Albrecht HH, O'Mullane J, Daggy BP: Cholesterol lowering with high-viscosity hydroxypropylmethylcellulose. Am J Cardiol 1999;84:1198-1203.
37. Dressman JB, Adair CH, Barnett JL, Berardi RR, Dunn-Kucharski VA, Jarvenpaa KM, Parr DD, Sowle CA, Swidan SZ, Tobey SW, Reppas C: High molecular weight hydroxypropylmethylcellulose. A cholesterol-lowering agent. Arch Intern Med 1993;153:1345-1353.